Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00345553 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biliary Atresia Study in Infants and Children

Study acronym: BASIC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 16 sitesv36
  2. Re-verified, no change to tracked fieldsv35
  3. Secondary endpoints: 2 to 1v34 Show 4 more changesShow less
    • Study description shortened, about 49 words
    • Site details revised at 10 of 16 sites
    • Study arms: 2 to 1
    • Eligibility criteria shortened, about 3 words
  4. Primary and study completion dates: May 2029 to May 31, 2029v33
  5. Primary and study completion dates: May 2024 to May 2029v32
Show 30 earlier versionsHide 30 earlier versions
  1. Site contacts updated at 5 of 16 sitesv31
  2. Site contacts updated at 1 of 16 sitesv30
  3. Re-verified, no change to tracked fieldsv29
  4. Site contacts updated at 10 of 16 sitesv28
  5. Start date: May 2006 to May 16, 2006v27
  6. Trial status: Suspended to Recruiting
    • Site details revised at 16 of 16 sites
    v26
  7. Trial status: Recruiting to Suspended Sponsor's reason: Study visits suspended due to COVID-19 pandemic.
    • Site details revised at 16 of 16 sites
    v25
  8. Secondary endpoints revised (2)
    • Site contacts updated at 2 of 16 sites
    v24
  9. Site contacts updated at 3 of 16 sitesv23
  10. Primary and study completion dates: May 2019 to May 2024
    • Study sites revised (16)
    v22
  11. Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description expanded, about 9 words
    • Study sites revised (16)
    v21
  12. Site contacts updated at 2 of 16 sitesv20
  13. Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Arbor Research Collaborative for Health
    • Site contacts updated at 12 of 16 sites
    • Collaborators expanded, about 10 words
    v19
  14. Study sites: 15 to 16v18
  15. Eligibility criteria shortened, about 5 wordsv17
  16. Primary completion date: May 2019
    • Study completion date: Jun 2014 to May 2019
    • Study sites revised (15)
    v16
  17. Enrollment target: 1200 to 1265
    • Study completion date: Dec 2012 to Jun 2014
    v15
  18. Enrollment target: 500 to 1200
    • Study sites: 10 to 15
    • Study completion date: Jun 2012 to Dec 2012
    v14
  19. 8 versions Re-verified since Jul 11, 2008, no change to tracked fieldsv6-v13
  20. Site contacts updated at 2 of 10 sitesv5
  21. 2 versions Re-verified since Feb 5, 2007, no change to tracked fieldsv3-v4
  22. Site details revised at 8 of 10 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To characterize the natural history of the older, non-transplanted child with BA.
Trial Details
NCT Number NCT00345553
Lead Sponsor Arbor Research Collaborative for Health
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Biliary Atresia
Related terms Biliary Atresia, Cholestasis
Enrollment 1,265 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov